Navigation Links
Asymchem Laboratories Hires Three New Employees: Guojie Xu, Pingzhong Huang, and Xiaojun Huang
Date:4/23/2010

MORRISVILLE, N.C., April 23 /PRNewswire/ -- Asymchem Laboratories is proud to announce and welcome Dr. Guojie (George) Xu as Director of Formulation Development, Dr. Pingzhong Huang as Director of Chemical Development, and Dr. Xiaojun Huang as Senior Director of Chemical Development.

Dr. Guojie (George) Xu joined Asymchem on February 1, 2010.  He brings extensive scientific and managerial experience in pharmaceutical formulations to Asymchem.    Dr. Xu was most recently Product Development Manager at Sandoz, where he held roles of increasing responsibility over 10 year.  Educated in China, he went on to earn a Ph.D. in Pharmaceutics from Meijo University in Japan and held appointments at Shenyang Pharmaceutical University, Beijing Institute for Pharmacology & Toxicology, and the University of Chicago.  Dr. Xu splits his time between Asymchem's Morrisville, NC headquarters and Life Science Center in Tianjin, China.

Dr. Pingzhong Huang joined Asymchem on March 15, 2010.  He brings 15 years of experience in contract synthesis and pharmaceutical process chemistry to the job, most recently at Wyeth in Pearl River, New York where he was a Senior Research Scientist in the Chemical Sciences group.  Dr. Huang graduated from Peking University and earned a Ph.D. in synthetic organic chemistry at the University of Geneva.  Dr. Huang splits his time between Asymchem's Morrisville, NC headquarters and Life Science Center in Tianjin, China.

Dr. Xiaojun Huang will be joining Asymchem on April 26, 2010.  Dr. Huang has previous experience at Roche, where he was a research scientist in Palo Alto, California, and Pfizer in La Jolla, California.  He has degrees in chemistry from Fudan University in Shanghai and the University of Edmonton and also held a postdoctoral appointment at Stanford University with Barry Trost. Dr. Huang will be based at Asymchem's Life Science Center in Tianjin, China.

Asymchem Laboratories is a leading research-based contract manufacturer specializing in the development and compliant manufacturing (Contract Research and Manufacturing Services) of API's and Drug Products serving the pharmaceutical industry. With a 15 yr track record, Asymchem is committed to the highest level of quality and excellence in the integrated CMC services arena.  For further information, please visit the Asymchem website at www.asymchem.com or contact Leigh-Anne Ronk at 919-468-3884.

               


'/>"/>
SOURCE Asymchem Laboratories
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Three Steps to Boost Asymchems Investment in China
2. Pfizer Global R&D Presents 2008 Top Intermediates CMO Award to Asymchem
3. Dr. Chris Huber Joins Asymchem Laboratories Inc. as Director of Chemical Development
4. Codexis Appoints Singapore Laboratories Managing Director
5. ARUP Laboratories and Premier Extend Contract for Reference Laboratory Testing Services
6. Forest Laboratories Announces Federal Appeals Court Upholds Lexapro(R) Patent Decision
7. Microbia and Forest Laboratories Announce Linaclotide Co-Development and Co-Marketing Collaboration
8. Stiefel Laboratories Appoints Two New Members to Board of Directors
9. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Methimazole Tablets USP, 5 mg and 10 mg
10. ARUP Laboratories Releases ARUP Consult(R) 2.0
11. Forest Laboratories Lexapro and Generics-Dominated Fluoxetine Lead First-Line Therapy in the Treatment for Major Depression
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers and fluorometers ... the 6000i models are higher end machines that use the more unconventional z-dimension of ... beam from the bottom of the cuvette holder. , FireflySci has developed several ...
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)... 2016  The Biodesign Challenge (BDC), a university competition ... harness living systems and biotechnology, announced its winning teams ... New York City . The ... projects at MoMA,s Celeste Bartos Theater during the daylong ... senior curator of architecture and design, and Suzanne ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
Breaking Biology Technology:
(Date:3/31/2016)... R.I. , March 31, 2016  Genomics firm ... of founding CEO, Barrett Bready , M.D., who ... members of the original technical leadership team, including Chief ... President of Product Development, Steve Nurnberg and Vice President ... returned to the company. Dr. Bready served ...
(Date:3/23/2016)... March 23, 2016 ... Sicherheit Gesichts- und Stimmerkennung mit Passwörtern ... (NASDAQ: MESG ), ein führender Anbieter ... Unternehmen mit SpeechPro zusammenarbeitet, um erstmals dessen ... wird die Möglichkeit angeboten, im Rahmen mobiler ...
(Date:3/22/2016)... Ontario , PROVO and ... Newborn Screening Ontario (NSO), which operates the ... for molecular testing, and Tute Genomics and UNIConnect, ... management technology respectively, today announced the launch of a ... next-generation sequencing (NGS) testing panel. NSO ...
Breaking Biology News(10 mins):